Membrane Aerated Biofilm Reactor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Modules, Containerized, Concrete Plants), By Application (Municipal, Industrial), By Treatment Capacity (1 m3/d - 50 m3/d, 50 m3/d - 150 m3/d, 150 m3/d - 500 m3/d, Above 500 m3/d), By Region & Competition, 2021-2031F

January 2026 | 180 pages | ID: MD3A29D0829FEN
TechSci Research

Abstracts

The Global Membrane Aerated Biofilm Reactor Market is projected to expand from USD 1.86 Billion in 2025 to USD 2.59 Billion by 2031, reflecting a compound annual growth rate of 5.67%. This biological wastewater treatment method leverages gas-permeable membranes to supply oxygen directly to a biofilm, facilitating simultaneous nitrification and denitrification within a single reactor. By utilizing bubble-free aeration, the process achieves superior oxygen transfer efficiency relative to traditional diffusion techniques. Growth in this sector is primarily fueled by stricter nutrient removal mandates and the need to retrofit aging facilities to boost capacity without enlarging their physical footprint. Additionally, the industry's push toward energy neutrality fosters adoption, as these systems provide significant operational cost savings through enhanced aeration mechanics.

However, broad market expansion is hindered by the substantial initial capital investment needed for specialized membrane modules and the technical difficulties involved in long-term biofilm control and fouling management. These maintenance requirements can be a deterrent for smaller municipalities lacking extensive technical capabilities. Despite these obstacles, operational efficiency remains a compelling advantage for utility operators. According to the International Water Association's 2024 report, MABR technology can lower aeration energy usage by as much as 50% compared to conventional activated sludge systems, establishing it as a vital element in sustainable urban water management strategies.

Market Driver

The necessity to upgrade and retrofit aging infrastructure acts as a primary catalyst for growth, largely because MABR technology enables utilities to increase treatment capacity within existing basin boundaries. This "drop-in" functionality is crucial for municipalities encountering rigorous nutrient discharge regulations yet lacking the space or funds for new civil construction. By suspending membrane modules directly into existing anoxic zones, operators can support both nitrifying biofilms and suspended sludge, leading to marked performance improvements. For example, WaterProjectsOnline noted in December 2024 that the retrofit of Severn Trent Water?s Monkmoor Sewage Treatment Works, using 48 OxyMem MABR modules, achieved an ammonia removal rate of 243 kilograms of nitrogen daily, exceeding the design target of 162 kilograms.

Concurrently, rapid urbanization and expanding industrial activities are driving adoption, as high-load manufacturing plants require effective solutions for complex effluents. Industries such as food processing and paper manufacturing are increasingly utilizing these reactors to manage high-strength wastewater while meeting environmental standards. Fluence Corporation highlighted this demand in March 2024 by securing a $2.3 million contract for a 7,500 cubic meter per day MABR plant at an Italian recycled paper mill. The market momentum generated by these factors is reflected in regional procurement figures; Fluence Corporation reported in March 2024 that it secured $3.3 million in North American municipal bookings during the first two months of the year, surpassing the region's total sales for the previous year.

Market Challenge

The substantial initial capital outlay required for specialized membrane modules poses a significant obstacle to the widespread implementation of Membrane Aerated Biofilm Reactor technology. Although the system offers long-term operational cost reductions, the upfront investment for these advanced aeration units is considerably higher than that for traditional diffusers. This financial challenge is exacerbated by the technical complexities involved in managing biofilm thickness and mitigating fouling, tasks that demand skilled staff and strict maintenance routines often missing in smaller utility operations. As a result, risk-averse municipal leaders frequently postpone upgrading to this efficient architecture, considering the immediate acquisition and training expenses to be prohibitive despite the promise of future efficiency enhancements.

This reluctance is further entrenched by the general financial stress impacting the global water sector, where constrained budgets struggle to support premium infrastructure spending. According to the International Water Association, in 2024, environmental fees related to wastewater treatment constituted more than 50% of the total water bill in one-third of cities surveyed globally. This figure highlights the severe pressure on utility budgets, which directly restricts the fiscal ability of operators to bear the high costs linked to deploying advanced MABR infrastructure. Such financial limitations effectively impede market growth by limiting access to only the most well-funded utility providers.

Market Trends

The rise of modular and containerized MABR units is transforming the market by offering flexible, plug-and-play treatment options for decentralized uses. Unlike centralized systems that demand extensive civil engineering, these pre-packaged solutions enable municipalities and private developers to quickly establish biological treatment capacity in remote or space-limited areas. This delivery approach drastically cuts installation times and upfront construction expenses, making high-performance nutrient removal attainable for smaller communities and commercial projects lacking the funds for custom facilities. The commercial success of this sector is growing; Fluence Corporation?s April 2024 'Quarterly Activities Report' noted that its Smart Product Solutions division, which houses its modular MABR line, saw a 50% revenue jump in the first quarter compared to the same period the prior year.

At the same time, the market is moving decisively toward energy-neutral and low-carbon operations, motivated by the global water sector's dedication to net-zero emission goals. Utilities are increasingly selecting MABR technology not merely for regulatory compliance, but as a strategic asset to disconnect wastewater treatment from high electricity usage and the resulting carbon footprints. By employing passive aeration membranes that remove the need for energy-consuming blowers, these systems substantially reduce Scope 2 emissions, warranting premium investments through long-term sustainability benefits. This strategic direction is clear in major utility spending; as reported by Water Industry Journal in March 2024, Severn Trent Water allocated ?6.2 million for the Monkmoor MABR upgrade specifically to align the plant's enhanced treatment capacity with the company's wider carbon reduction objectives.

Key Market Players

• Xylem Inc.
• Pentair plc
• Aqua-Aerobic Systems, Inc.
• EnviroChemie GmbH
• BASF SE
• Emerson Electric Co.
• ITT Inc.
• Tetra Tech, Inc.

Report Scope

In this report, the Global Membrane Aerated Biofilm Reactor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Membrane Aerated Biofilm Reactor Market, By Type
• Modules
• Containerized
• Concrete Plants
• Membrane Aerated Biofilm Reactor Market, By Application
• Municipal
• Industrial
• Membrane Aerated Biofilm Reactor Market, By Treatment Capacity
• 1 m3/d - 50 m3/d
• 50 m3/d - 150 m3/d
• 150 m3/d - 500 m3/d
• Above 500 m3/d
• Membrane Aerated Biofilm Reactor Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Aerated Biofilm Reactor Market.

Available Customizations:

Global Membrane Aerated Biofilm Reactor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Type (Modules, Containerized, Concrete Plants)
  5.2.2. By Application (Municipal, Industrial)
  5.2.3. By Treatment Capacity (1 m3/d - 50 m3/d, 50 m3/d - 150 m3/d, 150 m3/d - 500 m3/d, Above 500 m3/d)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Type
  6.2.2. By Application
  6.2.3. By Treatment Capacity
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Membrane Aerated Biofilm Reactor Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Type
      6.3.1.2.2. By Application
      6.3.1.2.3. By Treatment Capacity
  6.3.2. Canada Membrane Aerated Biofilm Reactor Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Type
      6.3.2.2.2. By Application
      6.3.2.2.3. By Treatment Capacity
  6.3.3. Mexico Membrane Aerated Biofilm Reactor Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Type
      6.3.3.2.2. By Application
      6.3.3.2.3. By Treatment Capacity

7. EUROPE MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Type
  7.2.2. By Application
  7.2.3. By Treatment Capacity
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Membrane Aerated Biofilm Reactor Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Type
      7.3.1.2.2. By Application
      7.3.1.2.3. By Treatment Capacity
  7.3.2. France Membrane Aerated Biofilm Reactor Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Type
      7.3.2.2.2. By Application
      7.3.2.2.3. By Treatment Capacity
  7.3.3. United Kingdom Membrane Aerated Biofilm Reactor Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Type
      7.3.3.2.2. By Application
      7.3.3.2.3. By Treatment Capacity
  7.3.4. Italy Membrane Aerated Biofilm Reactor Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Type
      7.3.4.2.2. By Application
      7.3.4.2.3. By Treatment Capacity
  7.3.5. Spain Membrane Aerated Biofilm Reactor Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Type
      7.3.5.2.2. By Application
      7.3.5.2.3. By Treatment Capacity

8. ASIA PACIFIC MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Type
  8.2.2. By Application
  8.2.3. By Treatment Capacity
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Membrane Aerated Biofilm Reactor Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Type
      8.3.1.2.2. By Application
      8.3.1.2.3. By Treatment Capacity
  8.3.2. India Membrane Aerated Biofilm Reactor Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Type
      8.3.2.2.2. By Application
      8.3.2.2.3. By Treatment Capacity
  8.3.3. Japan Membrane Aerated Biofilm Reactor Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Type
      8.3.3.2.2. By Application
      8.3.3.2.3. By Treatment Capacity
  8.3.4. South Korea Membrane Aerated Biofilm Reactor Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Type
      8.3.4.2.2. By Application
      8.3.4.2.3. By Treatment Capacity
  8.3.5. Australia Membrane Aerated Biofilm Reactor Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Type
      8.3.5.2.2. By Application
      8.3.5.2.3. By Treatment Capacity

9. MIDDLE EAST & AFRICA MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Type
  9.2.2. By Application
  9.2.3. By Treatment Capacity
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Membrane Aerated Biofilm Reactor Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Type
      9.3.1.2.2. By Application
      9.3.1.2.3. By Treatment Capacity
  9.3.2. UAE Membrane Aerated Biofilm Reactor Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Type
      9.3.2.2.2. By Application
      9.3.2.2.3. By Treatment Capacity
  9.3.3. South Africa Membrane Aerated Biofilm Reactor Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Type
      9.3.3.2.2. By Application
      9.3.3.2.3. By Treatment Capacity

10. SOUTH AMERICA MEMBRANE AERATED BIOFILM REACTOR MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Type
  10.2.2. By Application
  10.2.3. By Treatment Capacity
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Membrane Aerated Biofilm Reactor Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Type
      10.3.1.2.2. By Application
      10.3.1.2.3. By Treatment Capacity
  10.3.2. Colombia Membrane Aerated Biofilm Reactor Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Type
      10.3.2.2.2. By Application
      10.3.2.2.3. By Treatment Capacity
  10.3.3. Argentina Membrane Aerated Biofilm Reactor Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Type
      10.3.3.2.2. By Application
      10.3.3.2.3. By Treatment Capacity

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL MEMBRANE AERATED BIOFILM REACTOR MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Xylem Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Pentair plc
15.3. Aqua-Aerobic Systems, Inc.
15.4. EnviroChemie GmbH
15.5. BASF SE
15.6. Emerson Electric Co.
15.7. ITT Inc.
15.8. Tetra Tech, Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER